by Chris Lieu, Ph.D. | Jan 18, 2020 | Analysis, M&A
Over the last three years, there have been eight cancer cell therapy M&A deals for advanced first generation and next gen cancer cell therapy companies. Six of them have been completed to date. Data for this analysis was compiled using the DealForma biopharma...
